Pharma commercial teams cannot rapidly digitalize their go-to-market strategy to compete with digital-native health companies

Pharmaceutical companies are losing competitive advantage because their commercial teams lack the digital infrastructure, processes, and capabilities to match the speed and innovation of digital health competitors. Current pharma systems are built around legacy efficiency improvements rather than fundamental business model reinvention, causing them to miss market opportunities and fail to attract digitally-savvy healthcare providers and patients who expect modern, integrated engagement experiences.